Why the study?
Does contemporary breast cancer chemotherapy alter markers of aortic stiffness such as PWV and distensibility?
Does contemporary breast cancer chemotherapy alter markers of aortic stiffness such as PWV and distensibility?
Contemporary breast cancer chemotherapy, particularly anthracyclines, is associated with acute increases in aortic stiffness that only partially reverse one year after treatment discontinuation.
Answers are grounded in this paper and cite their sources.
May support aortic stiffness monitoring during breast cancer chemotherapy; hypothesis-generating for long-term cardiovascular risk.
Acute changes are observed in PWV and distensibility at the AA following contemporary breast cancer chemotherapy and partially reverse a year after therapy is discontinued, with more severe effects seen with anthracyclines.
No takes yet. Share an insight, caveat, or question.
Grover et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: